These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 11275655

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Current drug treatment options in neonatal hyperbilirubinaemia and the prevention of kernicterus.
    Rubaltelli FF.
    Drugs; 1998 Jul; 56(1):23-30. PubMed ID: 9664196
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004).
    Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM.
    J Perinatol; 2009 Feb; 29 Suppl 1():S25-45. PubMed ID: 19177057
    [Abstract] [Full Text] [Related]

  • 5. Understanding and preventing severe neonatal hyperbilirubinemia: is bilirubin neurotoxity really a concern in the developed world?
    Kaplan M, Hammerman C.
    Clin Perinatol; 2004 Sep; 31(3):555-75, x. PubMed ID: 15325538
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation and treatment of jaundice in the term newborn: a kinder, gentler approach.
    Newman TB, Maisels MJ.
    Pediatrics; 1992 May; 89(5 Pt 1):809-18. PubMed ID: 1579380
    [Abstract] [Full Text] [Related]

  • 8. Management of neonatal hyperbilirubinemia: pediatricians' practices and educational needs.
    Petrova A, Mehta R, Birchwood G, Ostfeld B, Hegyi T.
    BMC Pediatr; 2006 Mar 06; 6():6. PubMed ID: 16519797
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
    Sarici SU, Yurdakök M, Serdar MA, Oran O, Erdem G, Tekinalp G, Yiğit S.
    Pediatrics; 2002 Apr 06; 109(4):e53. PubMed ID: 11927726
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hyperbilirubinemia in the newborn.
    Lauer BJ, Spector ND.
    Pediatr Rev; 2011 Aug 06; 32(8):341-9. PubMed ID: 21807875
    [Abstract] [Full Text] [Related]

  • 15. Sn-Mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion.
    Kappas A, Drummond GS, Munson DP, Marshall JR.
    Pediatrics; 2001 Dec 06; 108(6):1374-7. PubMed ID: 11731664
    [Abstract] [Full Text] [Related]

  • 16. Evaluation and treatment of neonatal hyperbilirubinemia.
    Muchowski KE.
    Am Fam Physician; 2014 Jun 01; 89(11):873-8. PubMed ID: 25077393
    [Abstract] [Full Text] [Related]

  • 17. Trends in hospitalizations of newborns with hyperbilirubinemia and kernicterus in United States: an epidemiological study.
    Vidavalur R, Devapatla S.
    J Matern Fetal Neonatal Med; 2022 Dec 01; 35(25):7701-7706. PubMed ID: 34470114
    [Abstract] [Full Text] [Related]

  • 18. Update on Predicting Severe Hyperbilirubinemia and Bilirubin Neurotoxicity Risks in Neonates.
    Chang PW, Newman TB, Maisels MJ.
    Curr Pediatr Rev; 2017 Dec 01; 13(3):181-187. PubMed ID: 28117009
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.